| Literature DB >> 24727390 |
Jyh-Horng Sheu1, Yung-Husan Chen2, Yu-Hsin Chen2, Yin-Di Su3, Yu-Chia Chang4, Jui-Hsin Su5, Ching-Feng Weng6, Chia-Hung Lee7, Lee-Shing Fang8, Wei-Hsien Wang9, Zhi-Hong Wen1, Yang-Chang Wu10, Ping-Jyun Sung11.
Abstract
The structures, names, bioactivities and references of 138 briarane-type diterpenoids, including 87 new compounds, are summarized in this review. All the briarane-type compounds mentioned in this review article were obtained from gorgonian corals including the genus Briareum, Dichotella, Junceella and Verrucella. Some of these compounds showed potential bioactivities.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24727390 PMCID: PMC4012436 DOI: 10.3390/md12042164
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Scheme 1The carbon skeleton of briarane-type compounds.
New briaranes from B. asbestinum.
| Structure | No. | Name | Bioactivity | Ref. |
|---|---|---|---|---|
| Briareolate ester J (R = OC(O)(CH2)4CH3) | [ | |||
| Briareolate ester K | EC50 (BG02) = 40 μM | [ | ||
| Briareolate ester L | EC50 (BG02, BxPC-3)
| [ | ||
| Briareolate ester M | EC50 (BG02) = 8.0 μM briarane | [ | ||
| Briareolate ester N (R = OC(O)(CH2)4CH3) | [ | |||
BG02 (human embryonic stem cell line), BxPC-3 (human pancreatic cancer cell line).
New briaranes from B. excavatum.
| Structure | No. | Name | Bioactivity | Ref. |
|---|---|---|---|---|
| Briacavatolide A (R1 = CH3, R2 = OH, R3 = β-OH) | - | [ | ||
| Briacavatolide B (R1 = CH2OAc, R2 = OAc, R3 = β-OH) | - | [ | ||
| Briacavatolide C (R1 = CH3, R2 = OAc, R3 = α-OC(O)(CH2)2CH3) | IC50 (HCMV) = 18 μM
| [ | ||
| Briacavatolide E (R1 = CH3, R2 = OH, R3 = α-OC(O)(CH2)2CH3) | - | [ | ||
| Briacavatolide D (R = CH2OH) | - | [ | ||
| Briacavatolide F | IC50 (HCMV) = 22 μM | [ |
HCMV (human cytomegalovirus).
New briaranes from Briareum spp.
| Structure | No. | Name | Bioactivity | Ref. |
|---|---|---|---|---|
| Brialalepolide A (R = OAc) | at concentrations of 30, 20 and 15 μM for compounds | [ | ||
| Brialalepolide B (R = OC(O)(CH2)4CH3) | [ | |||
| Brialalepolide C (R = OC(O)(CH2)6CH3) | compounds | [ | ||
| Briaroxalide A (R1 = R3 = OH, R2 = R4 = OAc) | [ | |||
| Briaroxalide B (R1 = R2 = OH, R3 = R4 = OAc) | [ | |||
| Briaroxalide C (R1 = OH, R2 = R3 = R4 = OAc) | [ | |||
| Briaroxalide D (R1 = R2 = R4 = OH, R3 = OAc) | [ | |||
| Briaroxalide E (R1 = R4 = OH, R2 = R3 = OAc) | [ | |||
| Briaroxalide F (R1 = R2 = R3 = OAc, R4 = OH) | [ | |||
| Briaroxalide G (R1 = R3 = R4 = OAc, R2 = OH) | [ | |||
| Briarenolide E | showed inhibitory effects on the generation of superoxide anion (inhibition rate = 23.7%) and release of elastase (inhibition rate = 28.3%) at 10 μg/mL | [ | ||
| Briarenolide F (R1 = OOH, R2 = OC(O)(CH2)2CH3) | showed inhibitory effects on the generation of superoxide anion (inhibition rate = 76.7%) (IC50 = 3.8 μg/mL) and release of elastase (inhibition rate = 27.5%) at 10 μg/mL | [ | ||
| Briarenolide G | showed inhibitory effects on the generation of superoxide anion (inhibition rate = 22.0%) and release of elastase (inhibition rate = 13.0%) at 10 μg/mL | [ | ||
COX-2 (cyclooxygenase-2 or prostaglandin-endoperoxide synthase 2), Caco-2 (human epithelial colon adenocarcinoma), RAW264.7 (mouse leukemic monocyte macrophage cell line).
New briaranes from D. gemmacea.
| Structure | No. | Name | Bioactivity | Ref. |
|---|---|---|---|---|
| Gemmacolide G (R1 = R2 = OAc) | IC50 (A549, MG63)
| [ | ||
| Gemmacolide I (R1 = OC(O)CH2CH(CH3)2, R2 = H) | IC50 (A549, MG63) = 20.6, 25.0 μM | [ | ||
| Gemmacolide J (R1 = OC(O)CH2CH(CH3)2, R2 = OAc) | IC50 (A549, MG63) ≤1.4, 79.8 μM briarane | [ | ||
| Gemmacolide K (R1 = OC(O)CH2OH, R2 = H, R3 = Cl, R4 = OC(O)CH2CH(CH3)2, R5 = OAc) | IC50 (A549, MG63) = 38.2, 45.9 μM | [ | ||
| Gemmacolide L (R1 = OC(O)CH2OC(O)CH2CH(CH3)2, R2 = H, R3 = Cl, R4 = OC(O)CH2CH(CH3)2, R5 = OAc) | - | [ | ||
| Gemmacolide M (R1 = R4 = OAc, R2 = OCH3, R3 = H, R5 = OC(O)CH2CH(CH3)2) | IC50 (A549) = 27.4 μM exhibited antifungal activity against | [ | ||
| Gemmacolide N (R1 = R2 = R4 = OAc, R3 = H, R5 = OCH3) | briaranes | [ | ||
| Gemmacolide O (R1 = OC(O)CH2OH, R2 = R3 = R4 = OAc, R5 = Cl) | [ | |||
| Gemmacolide P (R1 = R3 = R4 = OAc, R2 = OC(O)CH2CH(CH3)2, R5 = OH) | [ | |||
| Gemmacolide Q (R1 = OC(O)CH2OH, R2 = OC(O)CH2CH(CH3)2, R3 = R4 = OAc, R5 = OH) | [ | |||
| Gemmacolide R (R1 = OC(O)CH2OH, R2 = R3 = OAc, R4 = OC(O)CH2CH(CH3)2, R5 = OH | briaranes | [ | ||
| Gemmacolide S (R1 = OC(O)CH2OC(O)CH2CH(CH3)2, R2 = R4 = OAc, R3 = R5 = OC(O)CH2CH(CH3)2) | [ | |||
| Gemmacolide AA (R1 = OC(O)CH2OH, R2 = R3 = R4 = OAc, R5 = OCH3) | [ | |||
| Gemmacolide AB (R1 = OC(O)CH2OH, R2 = OC(O)CH2CH(CH3)2, R3 = R4 = OAc, R5 = OCH3) | [ | |||
| Gemmacolide AC (R1 = R3 = R4 = OAc, R2 = OC(O)CH2CH(CH3)2, R5 = OCH3) | [ | |||
| Gemmacolide AD (R1 = R3 = OAc, R2 = R4 = OC(O)CH2CH(CH3)2, R5 = OCH3) | [ | |||
| Gemmacolide AE (R1 = OC(O)CH2OC(O)CH2CH(CH3)2, R2 = R3 = H, R4 = OAc, R5 = OCH3) | [ | |||
| Gemmacolide AF (R1 = R3 = R4 = OAc, R2 = R5 = OC(O)CH2CH(CH3)2) | [ | |||
| Gemmacolide AG (R1 = R2 = R3 = R4 = OAc, R5 = OC(O)CH2CH(CH3)2) | [ | |||
| Gemmacolide AH (R1 = OC(O)CH2OC(O)CH2CH(CH3)2, R2 = R5 = OC(O)CH2CH(CH3)2, R3 = R4 = OAc) | [ | |||
| Gemmacolide AI (R1 = OC(O)CH2OC(O)CH2CH(CH3)2, R2 = OH, R3 = R4 = OAc, R5 = OC(O)CH2CH(CH3)2) | [ | |||
| Gemmacolide AJ (R1 = OC(O)CH2OC(O)CH2CH(CH3)2, R2 = OC(O)CH2CH(CH3)2, R3 = R4 = OAc, R5 = Cl) | [ | |||
| Gemmacolide AK (R1 = OC(O)CH2OH, R2 = R4 = OAc, R3 = OC(O)CH2CH(CH3)2, R5 = OCH3) | [ | |||
| Gemmacolide AL (R1 = OC(O)CH2OC(O)CH2CH(CH3)2, R2 = R4 = OAc, R3 = OC(O)CH2CH(CH3)2, R5 = OCH3) | [ | |||
| Gemmacolide AM (R1 = OC(O)CH2OC(O)CH2CH(CH3)2, R2 = R4 = OAc, R3 = OC(O)CH2CH(CH3)2, R5 = Cl) | briaranes | [ | ||
| Gemmacolide AN (R1 = OC(O)CH2OH, R2 = R4 = OAc, R3 = OC(O)CH2CH(CH3)2, R5 = Cl) | [ | |||
| Gemmacolide AO (R1 = OC(O)CH2OH, R2 = R3 = R5 = OC(O)CH2CH(CH3)2, R4 = OAc) | [ | |||
| Gemmacolide AP (R1 = OC(O)CH2OH, R2 = R3 = OAc, R4 = OC(O)CH2CH(CH3)2, R5 = Cl) | [ | |||
| Gemmacolide AQ (R1 = R2 = R3 = OAc, R4 = OC(O)CH2CH(CH3)2, R5 = OH) | [ | |||
| Gemmacolide AR (R1 = R2 = R3 = R5 = OAc, R4 = OC(O)CH2CH(CH3)2) | [ | |||
| Dichotellide F (R1 = OC(O)CH2OC(O)CH2CH(CH3)2, R2 = R3 = R4 = OAc, R5 = OCH3) | [ | |||
| Dichotellide G (R1 = OC(O)CH2OC(O)CH2CH(CH3)2, R2 = R4 = OAc, R3 = OC(O)CH2CH(CH3)2, R5 = OCH3) | [ | |||
| Dichotellide H (R1 = OC(O)CH2OC(O)CH2CH(CH3)2, R2 = OC(O)CH2CH(CH3)2, R3 = R4 = OAc, R5 = Cl) | [ | |||
| Dichotellide I (R1 = OC(O)CH2OC(O)CH2CH(CH3)2, R2 = R3 = R4 = OAc, R5 = OC(O)CH2CH(CH3)2) | [ | |||
| Dichotellide J (R1 = R2 = R3 = R4 = R5 = OAc) | [ | |||
| Dichotellide K (R1 = R2 = R4 = OAc, R3 = R5 = OC(O)CH2CH(CH3)2) | [ | |||
| Dichotellide L (R1 = R2 = R3 = OAc, R4 = R5 = OC(O)CH2CH(CH3)2) | [ | |||
| Dichotellide M (R1 = R4 = OAc, R2 = R3 = OC(O)CH2CH(CH3)2, R5 = OCH3) | [ | |||
| Dichotellide N (R1 = R2 = OAc, R3 = H, R4 = OC(O)CH2CH(CH3)2, R5 = OCH3) | [ | |||
| - | Dichotellide O (R1 = R4 = OAc, R2 = OC(O)CH2CH(CH3)2, R3 = H, R5 = OCH3) | - | [ | |
| Dichotellide P (R1 = R2 = OAc, R3 = H, R4 = R5 = OC(O)CH2CH(CH3)2) | [ | |||
| Dichotellide Q (R1 = OAc, R2 = R4 = OH, R3 = OC(O)CH2CH(CH3)2, R5 = Cl) | [ | |||
| Dichotellide R (R1 = OAc, R2 = R4 = OH, R3 = R5 = OC(O)CH2CH(CH3)2) | [ | |||
| Dichotellide S (R1 = R3 = OAc, R2 = R4 = OH, R5 = OC(O)CH2CH(CH3)2) | [ | |||
| Dichotellide U (R = CH2OC(O)CH2CH(CH3)2) | [ | |||
| Gemmacolide T (R1 = R4 = OAc, R2 = OC(O)CH2CH(CH3)2, R3 = H) | briaranes | [ | ||
| Gemmacolide U (R1 = R2 = OAc, R3 = H, R4 = OC(O)CH2CH(CH3)2) | [ | |||
| Gemmacolide V (R1 = R2 = R4 = OAc, R3 = H) | [ | |||
| Gemmacolide W (R1 = R3 = OC(O)CH2CH(CH3)2, R2 = R4 = OAc) | [ | |||
| Gemmacolide X (R = OAc) (=Dichotellide T) | [ | |||
| Gemmacolide Y (R = OC(O)CH2CH(CH3)2) | [ | |||
A549 (human lung epithelial carcinoma), MG63 (human osteosarcoma).
New briaranes from J. fragilis.
| Structure | No. | Name | Bioactivity | Ref. |
|---|---|---|---|---|
| Frajunolide L (R1 = R2 = OAc, R3 = CH3) | briaranes | [ | ||
| Frajunolide P (R1 = OC(O)C(CH3)3, R2 = H, R3 = C(O)OCH3) | [ | |||
| Frajunolide Q (R1 = OAc, R2 = H, R3 = C(O)OCH3) | [ | |||
| Frajunolide M | briaranes | [ | ||
| Frajunolide N | - | [ | ||
| Frajunolide O | - | [ | ||
| Frajunolide R | - | [ | ||
| Frajunolide S | - | [ |
New briarane metabolites from J. juncea.
| Structure | No. | Name | Bioactivity | Ref. |
|---|---|---|---|---|
| R = OC(O)CH2CH(CH3)2
| showed moderate activity against the fungi
| [ | ||
| Juncenolide M | briaranes | [ | ||
| Juncenolide N (R1 = OH, R2 = H, R3 = CH3) | - | [ | ||
| Juncenolide O (R1 = R2 = OAc, R3 = C(O)OCH3) | showed an inhibitory effect on the generation of superoxide anion (inhibition rate = 27.6%) at 10 μg/mL | [ |
This compound was named (1S*,2S*,8S*,9S*,10S*,11R*,12R*,14S*,17R*)-11,20-epoxy-14-(3-methylbutanoyl)-2,9,12,-triacetoxy-8-hydroxybriar-5(16)-en-18,7-olide. Because the stereochemistry of C-7 chiral carbon was not described, the stereochemistry of C-7 was assigned as S*-configuration by the structure of 84 [43].